2021
DOI: 10.1371/journal.pone.0247524
|View full text |Cite
|
Sign up to set email alerts
|

Phenol-chloroform-based RNA purification for detection of SARS-CoV-2 by RT-qPCR: Comparison with automated systems

Abstract: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly reached pandemic levels. Sufficient testing for SARS-CoV-2 has remained essential for tracking and containing the virus. SARS-CoV-2 testing capabilities are still limited in many countries. Here, we explore the use of conventional RNA purification as an alternative to automated systems for detection of SARS-CoV-2 by RT-qPCR. 87 clinical swab specimens were extracted by conventional phenol-chloroform RNA purification and compar… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 11 publications
(13 reference statements)
0
1
0
Order By: Relevance
“…In recent years, commercially available RNA extraction kits have largely replaced conventional RNA extraction approaches [7]. However, commercial systems and kits are costly, and they are not widely available in many countries [1,9]. Many resource-constrained institutions and laboratories lack enough or no research funding, making the use of commercial kits challenging.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In recent years, commercially available RNA extraction kits have largely replaced conventional RNA extraction approaches [7]. However, commercial systems and kits are costly, and they are not widely available in many countries [1,9]. Many resource-constrained institutions and laboratories lack enough or no research funding, making the use of commercial kits challenging.…”
Section: Discussionmentioning
confidence: 99%
“…Te use of commercial kits necessitates fewer blood samples and takes less time than existing traditional techniques [7]. However, commercial systems and kits are costly and are not readily available in many countries [1,9]. Many resource-constrained institutions and laboratories lack enough or no research funding, making the use of commercial kits challenging.…”
Section: Introductionmentioning
confidence: 99%
“…These approaches result in the concentration of viral RNA ( Graham et al., 2021 ). The commercial solutions for performing full viral RNA extraction include sophisticated and automated instruments ( Dimke et al., 2021 ; Genoud et al., 2021 ), or more simple, labor-intensive and ready-to-use extraction kits ( Wozniak et al., 2020 ; Ambrosi et al., 2021 ; Dimke et al., 2021 ) based on extractions with organic solvents, as well as solid-phase purification ( Klein et al., 2020 ; Graham et al., 2021 ) ( Table 2 ). The assessment of these instruments and kits already proved in numerous studies that a full extraction process plays a significant role in maximizing the recovery of SARS-CoV-2 RNA, increasing the sensitivity of the diagnostic process ( Israeli et al., 2020 ; Lübke et al., 2020 ).…”
Section: Sample Processingmentioning
confidence: 99%